147 related articles for article (PubMed ID: 26929762)
21. Evaluation of nuchal translucency measurement in first trimester pregnancy.
Barati M; Zargar M; Masihi S; Taherpour S
Int J Fertil Steril; 2011 Apr; 5(1):35-8. PubMed ID: 24917922
[TBL] [Abstract][Full Text] [Related]
22. Cystic hygromas, nuchal edema, and nuchal translucency at 11-14 weeks of gestation.
Molina FS; Avgidou K; Kagan KO; Poggi S; Nicolaides KH
Obstet Gynecol; 2006 Mar; 107(3):678-83. PubMed ID: 16507941
[TBL] [Abstract][Full Text] [Related]
23. First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population.
Brizot ML; Carvalho MH; Liao AW; Reis NS; Armbruster-Moraes E; Zugaib M
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):652-5. PubMed ID: 11844209
[TBL] [Abstract][Full Text] [Related]
24. Normal Intracranial Translucency Values During the First Trimester of Gestation in a Latin American Population.
Molina-Giraldo S; Pérez-Olivo JL; Arias JL; Acuña E; Alfonso D; Arreaza M; Leal MB
J Ultrasound Med; 2016 Oct; 35(10):2231-6. PubMed ID: 27582529
[TBL] [Abstract][Full Text] [Related]
25. Nuchal translucency measurements: frequency distribution and changes with gestation in a general population.
Braithwaite JM; Morris RW; Economides DL
Br J Obstet Gynaecol; 1996 Dec; 103(12):1201-4. PubMed ID: 8968236
[TBL] [Abstract][Full Text] [Related]
26. Nuchal translucency thickness measurements for fetal aneuploidy screening: Log NT-MoM or Delta-NT, performer-specific medians and ultrasound training.
Gyselaers WJ; Vereecken AJ; Van Herck EJ; Straetmans DP; Ombelet WU; Nijhuis JG
J Med Screen; 2006; 13(1):4-7. PubMed ID: 16569298
[TBL] [Abstract][Full Text] [Related]
27. Is nuchal translucency a useful aneuploidy marker in fetuses with crown-rump length of 28-44 mm?
Grande M; Solernou R; Ferrer L; Borobio V; Jimenez JM; Bennasar M; Soler A; Borrell A
Ultrasound Obstet Gynecol; 2014 May; 43(5):520-4. PubMed ID: 24006271
[TBL] [Abstract][Full Text] [Related]
28. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
29. [Increased nuchal translucency with normal karyotype].
Nicolaides KH; Wegrzyn P
Ginekol Pol; 2005 Aug; 76(8):593-601. PubMed ID: 16363364
[TBL] [Abstract][Full Text] [Related]
30. Impact of tissue harmonic imaging on measurement of nuchal translucency thickness.
Pasquini L; Tondi F; Rizzello F; Pontello V; Paoletti E; Fontanarosa M
Ultrasound Obstet Gynecol; 2010 Oct; 36(4):423-6. PubMed ID: 20205154
[TBL] [Abstract][Full Text] [Related]
31. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.
Pandya PP; Snijders RJ; Johnson SP; De Lourdes Brizot M; Nicolaides KH
Br J Obstet Gynaecol; 1995 Dec; 102(12):957-62. PubMed ID: 8652486
[TBL] [Abstract][Full Text] [Related]
32. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
[No Abstract] [Full Text] [Related]
33. [Evaluation of pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of human chorionic gonadotropin (beta hCG) levels and sonographic assesement of fetal nuchal translucency (NT) in singleton pregnancies between 11 and 14 weeks of gestation--Polish multi-centre research].
Borowski D; Czuba B; Cnota W; Hincz P; Czekierdowski A; Gajewska J; Jaczyńska R; Ceran A; Włoch A; Wyrwas D; Wiełgoś M; Szymusik I; Szaflik K; Sodowski K
Ginekol Pol; 2007 May; 78(5):384-7. PubMed ID: 17867331
[TBL] [Abstract][Full Text] [Related]
34. Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening.
Cheng CC; Bahado-Singh RO; Chen SC; Tsai MS
Int J Gynaecol Obstet; 2004 Jan; 84(1):5-9. PubMed ID: 14698823
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of copy number variation by CMA in fetus with increased nuchal translucency].
Du L; Xie HN; Zheng J; He M
Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):671-676. PubMed ID: 30369122
[No Abstract] [Full Text] [Related]
36. Performance of Common Down Syndrome Screening Methods Used in India with Construction of an Indian Normogram for Nuchal Translucency/Crown-Rump Length Measurements in 14,337 Subjects.
Kaul A; Radhakrishnan P
J Obstet Gynaecol India; 2019 Oct; 69(Suppl 2):142-146. PubMed ID: 31686747
[TBL] [Abstract][Full Text] [Related]
37. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
[TBL] [Abstract][Full Text] [Related]
38. First-trimester screening in pregnancies conceived by assisted reproductive technology: significance of gestational dating by oocyte retrieval or sonographic measurement of crown-rump length.
Gjerris AC; Loft A; Pinborg A; Tabor A; Christiansen M
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):612-7. PubMed ID: 18816495
[TBL] [Abstract][Full Text] [Related]
39. Do Early Fetal Measurements and Nuchal Translucency Correlate With Term Birth Weight?
Hackmon R; Librach C; Burwick R; Rodrigues N; Farine D; Berger H
J Obstet Gynaecol Can; 2017 Sep; 39(9):750-756. PubMed ID: 28733063
[TBL] [Abstract][Full Text] [Related]
40. Threshold of nuchal translucency for the detection of chromosomal aberration: comparison of different cut-offs.
Kim MH; Park SH; Cho HJ; Choi JS; Kim JO; Ahn HK; Shin JS; Han JY; Kim MY; Yang JH
J Korean Med Sci; 2006 Feb; 21(1):11-4. PubMed ID: 16479057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
